Clinical trial
Measurement of Beta Cell Death in Individuals With Cystic Fibrosis
NCT03713437 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Measurement of Beta Cell Death in Individuals With Cystic Fibrosis
- Lead sponsor
- University of Nebraska
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 4, 2019
- Completion date
- June 30, 2021
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis-related diabetes